Karolina Korhaz Rendelointezet
Mosonmagyarovar, Hungary
Hospital in Mosonmagyaróvár
Mosonmagyaróvár, Régi Vámház tér 2, 9200
About Karolina Korhaz Rendelointezet
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
4
Takeda
4
Galapagos NV
3
Artu Biologicals
2
Eli Lilly and Company
2
Ferring Pharmaceuticals
2
Amgen
1
CTI BioPharma
1
Gilead Sciences
1
Hoffmann-La Roche
1
Janssen Research & Development, LLC
1
Clinical Trials at Karolina Korhaz Rendelointezet
During the past decade, Karolina Korhaz Rendelointezet conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 12 clinical trials were completed, i.e. on
average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.
2005-12-01
2006-12-01
Terminated
600
Efficacy and Safety of Grass Pollen Sublingual Immunotherapy
2006-12-01
2008-03-01
Completed
605
Long-term Efficacy and Safety Study With Oralgen Grass Pollen
2007-08-01
2009-01-01
Completed
356
A Study To Investigate The Safety And Possible Clinical Benefit Of Multistem(r) In Patients With Moderate To Severe Ulcerative Colitis
2011-02-01
2014-11-01
Completed
105
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
2012-07-20
2016-05-27
Completed
593
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
2012-06-01
2015-06-01
Completed
547
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
2012-10-01
2020-08-06
Completed
944
Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
2015-01-08
2019-06-03
Completed
170
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Karolina Korhaz Rendelointezet" #1 sponsor was "Pfizer" with 4 trials, followed by "Takeda" with 4 trials
sponsored, "Galapagos NV" with 3 trials sponsored, "Artu Biologicals" with 2 trials sponsored and "Eli Lilly and Company"
with 2 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Karolina Korhaz Rendelointezet"
#1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Athersys, Inc" with 1 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Karolina Korhaz Rendelointezet
According to Clinical.Site data, the most researched conditions in "Karolina Korhaz Rendelointezet" are
"Ulcerative Colitis" (10 trials), "Crohn's Disease" (5 trials), "Colitis, Ulcerative" (4 trials), "Allergic Rhinoconjunctivitis" (2 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Karolina Korhaz Rendelointezet" in a lesser frequency.
Clinical Trials Intervention Types at Karolina Korhaz Rendelointezet
Most popular intervention types in "Karolina Korhaz Rendelointezet" are "Drug" (22 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Filgotinib" (4 trials), "CP-690,550" (2 trials), "Mesalamine" (2 trials) and "Oralgen" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Karolina Korhaz Rendelointezet
The vast majority of trials in "Karolina Korhaz Rendelointezet" are
21 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Karolina Korhaz Rendelointezet
Currently, there are NaN active trials in "Karolina Korhaz Rendelointezet".
undefined are not yet recruiting,
1 are recruiting,
4 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 15 completed trials in Karolina Korhaz Rendelointezet,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Karolina Korhaz Rendelointezet, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 18 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".